Laboratory Corporation of America Holdings (LH)

NYSE: LH · IEX Real-Time Price · USD
241.57
-0.20 (-0.08%)
Dec 2, 2022 4:00 PM EST - Market closed
-0.08%
Market Cap 21.42B
Revenue (ttm) 15.26B
Net Income (ttm) 1.76B
Shares Out 90.40M
EPS (ttm) 18.78
PE Ratio 12.86
Forward PE 13.16
Dividend $2.16 (0.89%)
Ex-Dividend Date Nov 16, 2022
Volume 739,918
Open 238.91
Previous Close 241.77
Day's Range 237.26 - 241.91
52-Week Range 200.32 - 317.17
Beta 1.06
Analysts Buy
Price Target 284.03 (+17.6%)
Earnings Date Oct 27, 2022

About LH

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C ... [Read more]

Industry Health Care Providers & Services
Founded 1971
CEO Adam Schechter
Employees 75,000
Stock Exchange NYSE
Ticker Symbol LH
Full Company Profile

Financial Performance

In 2021, LH's revenue was $16.12 billion, an increase of 15.33% compared to the previous year's $13.98 billion. Earnings were $2.38 billion, an increase of 52.77%.

Financial Statements

Analyst Forecast

According to 24 analysts, the average rating for LH stock is "Buy." The 12-month stock price forecast is 284.03, which is an increase of 17.58% from the latest price.

Price Target
$284.03
(17.58% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Oracle Cerner Technology to Manage Hospital Labs in 10 States

Cerner's lab information systems selected to help Labcorp streamline operations and enhance patient experiences for a leading health system  KANSAS CITY, Mo. , Nov. 14, 2022 /PRNewswire/ -- Oracle Cerne...

2 weeks ago - PRNewsWire

Why Labcorp Stock Sank by Almost 6% on Thursday

No investor likes when their company trims its guidance.

1 month ago - The Motley Fool

LabCorp (LH) Misses Q3 Earnings Estimates, Updates Guidance

LabCorp's (LH) organic revenues decline significantly, mainly due to major decrease in COVID-19 PCR and antibody testing sales.

1 month ago - Zacks Investment Research

LabCorp (LH) Q3 Earnings and Revenues Miss Estimates

LabCorp (LH) delivered earnings and revenue surprises of -0.64% and 5.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Labcorp's stock falls 4% after COVID-19 test sales decline in the third quarter

Shares of Labcorp LH, +0.76% tumbled 4.7% in premarket trading on Thursday after the diagnostics company said revenue in the third quarter of 2022 came in lower than expected as fewer people got PCR or ...

1 month ago - Market Watch

Labcorp Announces 2022 Third Quarter Results

BURLINGTON, N.C.

1 month ago - Business Wire

2 Health Care Stocks That Fit Graham's Lost Formula

U.S. market indexes rose on Thursday morning as investors were encouraged by several key earnings reports and Treasury yields continued to climb.

Other symbols: IRWD
1 month ago - GuruFocus

Analysts Estimate LabCorp (LH) to Report a Decline in Earnings: What to Look Out for

LabCorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Labcorp CEO Adam Schechter on COVID-19, flu season, home testing advances, health equity, and more

Labcorp CEO Adam Schechter speaks about various aspects of the heath care industry at Yahoo Finance's All Markets Summit.

1 month ago - Yahoo Finance

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C.

1 month ago - Business Wire

Labcorp Establishes Comprehensive Laboratory Relationship With Ascension

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the completion of transactions that establish a long-term laboratory relationship with Asce...

2 months ago - Business Wire

Labcorp to Announce Third Quarter Financial Results on October 27, 2022

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct. ...

2 months ago - Business Wire

Analysts Totally Blow It On 12 Gutsy Stock Recommendations

Wall Street analysts follow S&P 500 stocks more closely than almost anyone. But even they get it wrong sometimes, too.

2 months ago - Investors Business Daily

Labcorp to Speak at the Baird 2022 Global Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Ba...

2 months ago - Business Wire

Labcorp Acquires Clinical Outreach Laboratory Services From RWJBarnabas Health

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of RWJBarnabas Health's outreach laboratory business and...

3 months ago - Business Wire

10 defensive stocks that can also provide you with growth and dividends over the long term

The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.

3 months ago - Market Watch

BD, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics for Matching Patients with Treatments

Companies combine key capabilities to advance flow cytometry as an essential companion diagnostic modality for cancer and other diseases FRANKLIN LAKES, N.J. , Aug. 9, 2022 /PRNewswire/ -- BD (Becton, D...

Other symbols: BDX
3 months ago - PRNewsWire

These 13 Beaten Down Stocks Look Attractive

Walt Disney, Bank of America, Uber Technologies, and 10 other stocks that could be bargains after 2022's market selloff. The vew from Boyar Value Group.

3 months ago - Barrons

These 3 Companies Are Taking on Monkeypox

A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.

Other symbols: DGXSIGA
3 months ago - The Motley Fool

Labcorp To Spin Off Clinical Development Business

LH, $257.94; Market Capitalization: $23.3 billion), a leading global life sciences company, announced that its Board of Directors authorized a plan to spin-off Clinical Development business into an inde...

4 months ago - Forbes

LabCorp (LH) Q2 Earnings Top Estimates, Raises '22 EPS View

LabCorp (LH) posts better-than-expected earnings in the second quarter and demonstrates continued strength in the organic Base Business.

4 months ago - Zacks Investment Research

LabCorp (LH) Q2 Earnings Beat Estimates

LabCorp (LH) delivered earnings and revenue surprises of 6.21% and 3.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Labcorp to spin off its clinical-development business

Shares of Labcorp LH, +1.03% gained 4.2% in premarket trading on Thursday after beating earnings expectations for the second quarter and announcing plans to spin off its clinical-development business, w...

4 months ago - Market Watch